Envenomations are a serious health problem in tropical countries1 25 . In Brazil around 20,000 envenomation cases occur every year, 2,000 of them only in the State of São Paulo1. About 80 % of the cases occurring in Botucatu area are caused by three species of Bothrops (B.jararaca, B. alternatus and B. neuwiedi)2.
Local and systemic alterations are occasioned by Bothrops venom when inoculated in humans19 20. Proteolytic venom fractions1 result in tissue necroses. Hemorrhagic and coagulant fractions act on the systemic level leading to vessel and blood changes7 9. Blood white cells, platelets and coagulant factor alterations are observed7. Coagulant factor changes have been demonstrated in vitro and ex vivo experiments7 14 16 . Factors II and X are activated with consequent fibrinogen consumption7 14 16 . Platelet changes have been observed in accidents caused by different snakes7 9 15 26. Thomazini et alii23 demonstrated adecreaseofplateletaggregation activity in patients bitten by Crotalus snakes. On the other hand, Zingali et alii27 showed an increase of platelet aggregation activity in vitro. Based on these data, the aggregant or anti-aggregant effect caused by different snake venoms is controversial23
The objectives of the present study were to evaluate the number and platelet function , as well as fibrinogen and FDP plasma levels in patients bitten by Bothrops snakes.
MATERIALS AND METHODS
Fourteen patients, bitten by Bothrops snakes, 10 males and 4 females aged 13-59 years, admitted to the Tropical Diseases Service of the School of Medicine of Botucatu/UNESP were studied. Blood samples were collected immediately after the patients' admission, 24, 48 hours and 8 days after the specific treatment for hemostatic system evaluation. All patients were treated with specific antivenom according to several authors1 20. :19-24, jan-mar, 1995. Fibrinogen plasma levels were measured by Ratnoff and Menzie method18. Platelet function was evaluated by stimulating aggregation with 1 micromol (/tm) and 3/im adenosine diphosphate , collagen and epinephrine from Helena Laboratories5 by using a Zenith platelet aggregation for the graphic record. Numerical score of platelets was made utilizing the Newbauer chamber method by phase contrast. Fibrin degradation product (FDP) levels were determined in serum through the latex proof with the American Dade reagents.
Statistical analyses were carried out using the Wilcoxon non-parametric proof or two dependent samples4. Table 1 shows fibrinogen plasma levels decreased before and after 24 hours after the specific treatment (p<0.05). Forty-eight hours later the level augmented and remained stable until 8 days. The number of platelets was low before, 24 and 48 hours after sped fic treatment returning to the normal on the 8th day (p<0.05). Table 2 shows platelet stimulation with l^m and 3/tm ADP. When stimulated by 1/im ADP, platelets were hypoaggregant until 48 hours after treatment with a tendency to normalization on the 8th day (p<0.05). When ADP concentration was increased to 3/xm, the platelets were hypoaggregant in the 24-hour evaluation tending to normalization after 48 hours (p<0.05). A2 X B2 X C2 X D2 ; A2 = B2 = C2 < D2; (p < 0,05) Table 3 shows no alteration when platelets were stimulated by collagen and epinephrine. Table 4 shows fibrinogen plasma levels and fibrin degradation products (FDP) increased in 5 out of 6 patients studied. Three patients presented values up to 40 micrograms/ml, while the other two presented levels of 10-40^g/ml. The only patient with normal FDP (< 10/xg/ml) values showed normal platelet activity and normal fibrinogen values. In this study, immediately and 24 hours after the accident, fibrinogen plasmatic levels showed a decrease, but were still within normal values. These normalized 48 hours after specific treatment. A possible action of "factor X activator" and "thrombin-like" fraction from B. jararaca venom may explain these alterations. "Factor X activator" from B. jararaca venom transforms factor X from blood into activated factor X. Prothrombin is transformed into thrombin by activated factor X. Thrombin is capable of producing fibrin by acting on fibrinogen16. Throm bin-like fractions act directly on fibrinogen molecule transforming it into fibrin. This effect is similar to that of human thrombin.
RESULTS

DISCUSSION
In this way, there will be plasmatic fibrinogen consumption and formation of fibrin degradation products(FDP)10 11 1222 as final consequences.
Bothrops venom besides acting on fibrinogen, also presents an effect on platelet, both in number and in function6 7 21 22.
Prado-Franceschi et alii17 studying rabbits inoculated with Crotalus durissus terrificus venom, observed a discreet low number of platelets and an increase in platelet aggregant activity. Zingali et alii27 described that pure Bothrops venom has a fraction that can stimulate platelet aggregation. These authors27 28 in 1992, described a new component of Bothrops venom which might inhibit platelet aggregation when induced by thrombin. Thomazini et alii23 observed platelet hypofunction in patients bitten by Crotalus durissus terrificus, when this was stimulated by 1/xmADP. In this work platelet number decreased until 8 days after specific treatment. Platelets also showed hypoaggregation when stimulated by 1/im and 3fim ADP. Patients who presented high FDP levels were those who had platelet hypofunction. Marcus101112 demonstrated the anti-aggregant action of fibrin degradation products. According to Santoro et alii22, platelet hypoaggregation observed may be explained by high levels of circulating FDP, which would have an inhibitory action on platlets due to competition with aggregant agents in platelet receptors. Vargaftig et alii24 evaluating convulxin fraction effect of Crotalus durissus terrificus observed that this fraction presented an aggregant action in vitro. Aggregation would occur by stimulating platelet receptors, releasing thromboxane A^, the platelet enzyme that facilitates platelet adhesion and aggregation m echanism s to the vascular subendothelium24. This action would lead to exhaustion of platelet reserves of thromboxane A2, causing hypofunction. In the present study, we observed normalization of platelet aggregation curves on the 8th day after specific treatment. As platelet medium lifetime is 8 days, it is possible that aggregant function recovery occur, by renewing platelets in blood circulation.
According to Benett and Vilaire3, platelets need a suitable level of extracellular fibrinogen for perfect functioning. When these levels are decreased, there is a loss of potency of aggregant agents on receptors causing, in the least analysis, an aggregation decrease.
In conclusion, patients bitten by Bothrops snakes presented fibrinogen consum ption, platelet hypofunction and increased fibrinogen degradation products (FDP), suggesting a relationship among these factors. :19-24, jan-mar, 1995. 
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